Sarfaraz Ahmedali Lakhani appointed as independent director

Management Changes View source PDF Explain this filing

CROWN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.4%Reaction day

₹111.00

prior close

₹110.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.6%-2.8% vs market

Industrial Products peers, median of 130sector-3.1%-2.3% vs sector

On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 2.3 pts less than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.2

15m

+0.2

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.4-2.6-2.8-3.1-2.3

Next day

-1.9-3.6+1.7-3.6+1.7

-7.2-5.8-1.4-6.5-0.7

-5.4-5.5+0.1-5.9+0.5

-5.4-3.8-1.6-4.2-1.2

-5.4pendingpending-4.1-1.3

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 130Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board appointed Sarfaraz Ahmedali Lakhani as an additional non-executive independent director effective October 20, 2026, subject to shareholder approval. His term will run for five years until October 19, 2031. He has over 40 years of experience in hospital and healthcare management and is not related to any promoter, director or key manager.

Likely market impact

The appointment adds experienced independent oversight but is not expected to have an immediate financial impact.